The newly published report by IMARC Group, titled ”Post Menopausal Osteoporosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the post menopausal osteoporosis market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.
What is post menopausal osteoporosis?
post menopausal osteoporosis is a type of osteoporosis that develops in women after menopause. It often does not cause noticeable symptoms until a fracture occurs. However, some common indications may be present, including a stooped posture (kyphosis), back pain, loss of height over time, greater susceptibility to fractures, particularly in the wrist, hip, and spine, etc. In many cases, fractures can occur with minimal trauma or even during routine daily activities. The diagnosis of post menopausal osteoporosis typically involves a combination of clinical assessment and diagnostic tests.
Request a Sample Report : https://www.imarcgroup.com/post-menopausal-osteoporosis-market/requestsample
What are the key drivers and trends in the post menopausal osteoporosis market?
The elevating cases of decline in estrogen levels during menopause that result in an imbalance between bone formation and bone resorption, thereby leading to a net loss of bone density, are primarily augmenting the post menopausal osteoporosis market. Additionally, the rising incidence of various associated risk factors, such as genetic predisposition, prolonged use of corticosteroids, excessive alcohol consumption, inadequate intake of calcium and vitamin D, lack of physical activity, etc., is further catalyzing the market growth. Besides this, the growing adoption of oral bisphosphonates, including alendronate and risedronate, to inhibit bone resorption and minimize the likelihood of fractures in patients is acting as another significant growth-inducing factor.
Furthermore, the increasing usage of novel sequential therapies involving the use of anabolic agents like teriparatide followed by antiresorptive medications for optimizing bone formation and reducing bone loss is also contributing to the market growth. Apart from this, the emerging popularity of the trabecular bone score (TBS) imaging technique, since it assesses the microarchitecture of trabecular bone and provides additional information about bone quality, fracture risk, and treatment response, is projected to fuel the post menopausal osteoporosis market over the forecasted period.
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the post menopausal osteoporosis market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the post menopausal osteoporosis market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Ask an Analyst for Report Customization with Table of Contents: https://www.imarcgroup.com/post-menopausal-osteoporosis-market
Key Questions Answered in this Report:
- How has the post menopausal osteoporosis market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the post menopausal osteoporosis market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the post menopausal osteoporosis market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Browse the Latest Research Report:
Acute Renal Failure Market Report 2023-2033
Macular Edema Market Report 2023-2033
Peripheral T-cell Lymphoma Market Report 2023-2033
Musculoskeletal Pain Market Report 2023-2033
This report will help you with:
- Identifying the key players operating in the post menopausal osteoporosis market and understanding their market dominance.
- Knowing the essential factors to consider when evaluating a post menopausal osteoporosis market, aiding in informed decision-making
- Understanding the driving forces behind the post menopausal osteoporosis market, enabling businesses to stay ahead of emerging trends and capitalize on opportunities.
- Examining the changing market behavior over time and strategically assessing competition, facilitating effective benchmarking and strategic planning.
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
